Methylation of TIMP3 in esophageal squamous cell carcinoma

World J Gastroenterol. 2008 Jan 14;14(2):203-10. doi: 10.3748/wjg.14.203.

Abstract

Aim: To measure the frequency of DNA methylation of the tissue inhibitor of metalloproteinase 3 (TIMP3) promoter and relate this to any change of gene expression in esophageal squamous cell carcinoma in patients from a region of high incidence in China.

Methods: Cancer cell lines were treated with or without the demethylating reagent 5-aza-2'-deoxycytidine. Methylation of the TIMP3 promoter was assessed in three regions by melt curve analysis and its expression was assessed by real-time RT-PCR. Tumors and proximal resection margins were obtained from 64 patients with esophageal squamous cell carcinoma from a region of high incidence in China. Methylation was assessed by melt curve analysis and expression by immunohistochemistry.

Results: Methylation in one of the three promoter regions assessed correlated with gene silencing in esophageal cell lines. A degree of methylation of TIMP3 was found in only four esophageal squamous cell carcinomas, and partial loss of TIMP3 protein expression in just one.

Conclusion: Methylation and loss of expression of TIMP3 occurs infrequently in esophageal squamous cell carcinoma in a region of high incidence in China.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Squamous Cell / ethnology
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / physiopathology*
  • Cell Line, Tumor
  • China / epidemiology
  • DNA Methylation*
  • Esophageal Neoplasms / ethnology
  • Esophageal Neoplasms / genetics
  • Esophageal Neoplasms / physiopathology*
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Tissue Inhibitor of Metalloproteinase-3 / genetics*

Substances

  • TIMP3 protein, human
  • Tissue Inhibitor of Metalloproteinase-3